Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: vorinostat|OTHER: laboratory biomarker analysis|PROCEDURE: biopsy|RADIATION: F-18 16 alpha-fluoroestradiol|PROCEDURE: positron emission tomography|DRUG: anastrozole|DRUG: letrozole|DRUG: exemestane|GENETIC: gene expression analysis
Sponsor: University of Washington
Collaborators: National Cancer Institute (NCI)